Embecta Corp.
- EMBC
- NASDAQ
- Medical - Instruments & Supplies
- Diabetes Care Devices
- Pen Needles/Insulin Delivery
- Medical devices
$6.27
Today −2.79%Quote Oct 16, 2026, 08:00 PM UTC
+20.81%over the last month
Max drawdown −4.7%From 1-month high −2.8%3 months +82.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$355.3M
Quote Oct 16
Next earnings
Nov 24
Expected, not confirmed
Analyst target
$5.00
−20.3% from here
Floor
$6.04
3.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EMBCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2026 revenue $271.7M
- Safety$36.7M13.5%
- Product and Service, Other$15.6M5.7%
- Manufacturing Facility$5.3M2.0%
- Other / not reported$214.1M78.8%
Industry
Medical - Instruments & Supplies
Employees
1,850